Sagimet Biosciences (SGMT) Other financing activities (2022 - 2025)
Sagimet Biosciences' (SGMT) quarterly Other financing activities came in at -$300000.0 in Q4 2025, up 67.78% year-on-year from -$178809.2 in Q4 2024, and down 200.0% quarter-over-quarter from $300000.0 in Q3 2025.
Sagimet Biosciences (SGMT) Other financing activities (2022 - 2025) Analysis & Trends
Sagimet Biosciences' Other financing activities history runs 4 years deep, the most recent figure standing at -$300000.0 for Q4 2025.
- On a quarterly basis, Other financing activities rose 67.78% year-over-year to -$300000.0 in Q4 2025; TTM through Dec 2025 was $14000.0, a 87.72% decrease from a year earlier, with the FY2024 full-year figure at $114000.0, down 96.76% from the prior year.
- Other financing activities declined to -$300000.0 in Q4 2025 per SGMT's latest filing, from $300000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $86.2 million in Q3 2023 and bottomed at -$82.6 million in Q4 2023.
- The 4-year median for Other financing activities is $77500.0 (2022), against an average of $368700.0.
- Across the five-year window, Other financing activities plunged 150360.0% in 2023 and surged 98.87% in 2024, its largest moves.
- Year by year, Other financing activities stood at $55000.0 in 2022, then plunged by 150360.0% to -$82.6 million in 2023, then jumped by 98.87% to -$931000.0 in 2024, then surged by 67.78% to -$300000.0 in 2025.
- Per Business Quant, the three latest SGMT Other financing activities figures stand at -$300000.0 (Q4 2025), $300000.0 (Q3 2025), and -$931000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sagimet Biosciences | 227.27 Mn | 227.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -300,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Dec 31, 2024 | -931,000.00 |
| Dec 31, 2024 | -931,000.00 |
| Sep 30, 2024 | 945,000.00 |
| Sep 30, 2024 | 945,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -82.64 Mn |
| Dec 31, 2023 | -82.64 Mn |
| Sep 30, 2023 | 86.16 Mn |
| Sep 30, 2023 | 86.16 Mn |
| Jun 30, 2023 | -136,000.00 |
| Jun 30, 2023 | -136,000.00 |
| Mar 31, 2023 | 136,000.00 |
| Mar 31, 2023 | 136,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Dec 31, 2022 | 55,000.00 |